![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, February 26, 2021 10:56:13 AM
Setting a limit price too far out of the money doesn’t actually do anything. The larger the spread, the less risk there is for the MM to borrow the shares. They constantly monitor the share price. In the case of TPTW in the 5-7c range, anything over a 50c limit would likely be ignored. If the price were to rise sharply, they would have plenty of time and room to exit their short position.
The better way to do it, if your broker allows, is that you can designate to your broker to prohibit loaning of your shares. This is actually how many firms make their money so not all will allow the designation. Some, even return a percentage of the loan to the holders as “interest” to encourage you to do so.
If you really want to “bust” a short (and I’m not even sure how you short an OTC stock, I’ve never managed an account that allowed it) the key is just to buy more in the open market. I was personally surprised volume was so low the day after the CEO investor call, which I thought was great. If the 50-60 people (beeps) I counted on the call all went out and bought more shares, the price would have gone higher this week. That is the only way to get it to move higher. Attract new buyers or have existing buyers buy more shares. It would have helped if the call included an update to revenues from the medical and telecom divisions, but as someone who was formerly listed, I can understand limiting forward looking comments.
Recent TPTW News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/28/2024 02:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 09:18:29 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 02:18:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/10/2024 09:24:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 10:18:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 07:47:35 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/13/2024 06:17:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:00:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 09:52:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:06:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/27/2023 08:11:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 05:43:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 01:31:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 08:21:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 07:44:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 05:49:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 07:18:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/05/2023 09:02:48 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM